IDEAYA Biosciences, Inc.
IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candid…
Biotechnology
US, South San Francisco [HQ]
Balance Sheet
7 Sheets · From 2023 to 2017Configuration
In Million USD. Margins, Growth Rates In %
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|
| Assets | 17.00 | 96.00 | 113.00 | 298.00 | 381.00 | 387.00 | 649.00 | |
|
Current
|
13.00 | 90.00 | 100.00 | 288.00 | 250.00 | 370.00 | 532.00 | |
| Cash And Equivalents | 5.00 | 20.00 | 34.00 | 72.00 | 92.00 | 68.00 | 157.00 | |
| Assets | 17.00 | 96.00 | 113.00 | 298.00 | 381.00 | 387.00 | 649.00 | |
| Accounts Receivables (AR) | - - | - - | - - | -1.00 | - - | - - | - - | |
| Inventory | - - | - - | - - | - - | -121.00 | -8.00 | 532.00 | |
| Short Term Investments | 7.00 | 69.00 | 64.00 | 211.00 | 154.00 | 296.00 | 368.00 | |
| Other Current Assets | - - | - - | 2.00 | 3.00 | 3.00 | 5.00 | -632.00 | |
|
Non Current
|
3.00 | 5.00 | 12.00 | 9.00 | 130.00 | 17.00 | 116.00 | |
| Property, Plant, Equipment (Net) | 3.00 | 5.00 | 9.00 | 9.00 | 8.00 | 8.00 | 8.00 | |
|
Intangible Assets
|
- - | - - | - - | - - | - - | - - | - - | |
| Goodwill | - - | - - | - - | - - | - - | - - | - - | |
| Long Term Investments | - - | - - | 1.00 | - - | 121.00 | 8.00 | 107.00 | |
| Other Non Current Assets | - - | - - | 1.00 | - - | - - | - - | - - | |
| Liabilities | 33.00 | 145.00 | 113.00 | 298.00 | 381.00 | 387.00 | 28.00 | |
|
Current
|
2.00 | 5.00 | 6.00 | 38.00 | 45.00 | 31.00 | 27.00 | |
| Accounts Payable | - - | - - | - - | - - | 1.00 | 1.00 | 2.00 | |
| Short Term Debt | - - | - - | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
| Deferred Revenue | - - | - - | 5.00 | 27.00 | 29.00 | 8.00 | - - | |
| Tax Payable | - - | - - | - - | - - | - - | - - | - - | |
| Other Current Liabilities | 1.00 | 3.00 | - - | 8.00 | 12.00 | 16.00 | 18.00 | |
|
Non Current
|
30.00 | 140.00 | 5.00 | 61.00 | 34.00 | 6.00 | 1.00 | |
| Long Term Debt | - - | - - | 5.00 | 5.00 | 3.00 | 1.00 | 1.00 | |
| Leasing Obligations | - - | - - | 6.00 | 6.00 | 5.00 | 3.00 | 2.00 | |
| Deferred Non Current Tax Liabilities | - - | - - | - - | - - | -31.00 | -5.00 | - - | |
| Other Non Current Liabilities | 30.00 | 140.00 | - - | - - | 31.00 | 5.00 | - - | |
| Equity | -15.00 | -48.00 | 100.00 | 198.00 | 301.00 | 349.00 | 621.00 | |
| Stockholders' Equity | -15.00 | -48.00 | 100.00 | 198.00 | 301.00 | 349.00 | 621.00 | |
| Retained Earnings | -16.00 | -50.00 | -92.00 | -126.00 | -176.00 | -235.00 | -348.00 | |
| Common Stock | - - | - - | - - | - - | - - | - - | - - | |
| Preferred Stock | - - | - - | 113.00 | - - | - - | - - | - - | |
| Profit | -11.00 | -34.00 | -38.00 | -32.00 | -47.00 | -54.00 | -112.00 | |
| Dividends | - - | - - | - - | - - | - - | - - | - - | |
| Minority Interest | - - | - - | - - | - - | - - | - - | - - | |
| Other Stockholders' Equity | - - | 1.00 | 79.00 | 325.00 | 478.00 | 587.00 | 968.00 | |
| Loss Other Compr. Income | - - | - - | - - | - - | - - | -2.00 | - - |